DI
Company Profile
DiaMedica Therapeutics, Inc.
Minneapolis, MN | Minnetonka, United States of America
Our Focus
Overview
Literature & Publications
Pipeline
Preeclampsia & Fetal Growth Restriction
Acute Ischemic Stroke
Clinical Trials
ReMEDy2 Trial
0Products
0People
0Events
0Locations
Overview
Company details and contact information.
About
About DiaMedica Therapeutics, Inc. DiaMedica Therapeutics is a clinical-stage biopharma company developing DM199, a recombinant form of KLK1, to improve outcomes in ischemic stroke. DM199 is being evaluated in the Phase 2/3 ReMEDy2 clinical trial.
- Website
- https://diamedica.com
- Address
- 301 Carlson Parkway Suite 210, Minneapolis, MN, 55305 | 301 Carlson Parkway, Minnetonka MN 55305, United States of America